
### [Orphanet:176](http://www.orpha.net/ORDO/Orphanet_176)
**Label:** Non-rhizomelic chondrodysplasia punctata

**Subclasses:** [Orphanet:79345](http://www.orpha.net/ORDO/Orphanet_79345) (Brachytelephalangic chondrodysplasia punctata), [Orphanet:79344](http://www.orpha.net/ORDO/Orphanet_79344) (Autosomal dominant chondrodysplasia punctata), [Orphanet:35173](http://www.orpha.net/ORDO/Orphanet_35173) (X-linked dominant chondrodysplasia punctata), [Orphanet:79347](http://www.orpha.net/ORDO/Orphanet_79347) (Chondrodysplasia punctata, Toriello type), [Orphanet:79346](http://www.orpha.net/ORDO/Orphanet_79346) (Chondrodysplasia punctata, tibial-metacarpal type), 

**Corr. equiv. classes:** [Orphanet:79347](http://www.orpha.net/ORDO/Orphanet_79347), [OMIM:602497](http://purl.obolibrary.org/obo/OMIM_602497), [Orphanet:35173](http://www.orpha.net/ORDO/Orphanet_35173), [OMIM:302960](http://purl.obolibrary.org/obo/OMIM_302960), [OMIM:302950](http://purl.obolibrary.org/obo/OMIM_302950), [OMIM:215105](http://purl.obolibrary.org/obo/OMIM_215105), [OMIM:118651](http://purl.obolibrary.org/obo/OMIM_118651), [OMIM:118650](http://purl.obolibrary.org/obo/OMIM_118650), [Orphanet:79344](http://www.orpha.net/ORDO/Orphanet_79344), [Orphanet:79345](http://www.orpha.net/ORDO/Orphanet_79345), [Orphanet:79346](http://www.orpha.net/ORDO/Orphanet_79346), 

**Class expressions from DL-Learner:**

- [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0010655](http://purl.obolibrary.org/obo/HP_0010655) (Epiphyseal stippling) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) 56.94%
- [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0001072](http://purl.obolibrary.org/obo/HP_0001072) (Thickened skin) and [HP:0010655](http://purl.obolibrary.org/obo/HP_0010655) (Epiphyseal stippling) 56.94%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0010655](http://purl.obolibrary.org/obo/HP_0010655) (Epiphyseal stippling) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) 56.94%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001072](http://purl.obolibrary.org/obo/HP_0001072) (Thickened skin) and [HP:0010655](http://purl.obolibrary.org/obo/HP_0010655) (Epiphyseal stippling) 56.94%
- [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0010655](http://purl.obolibrary.org/obo/HP_0010655) (Epiphyseal stippling) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 56.94%
- [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0010655](http://purl.obolibrary.org/obo/HP_0010655) (Epiphyseal stippling) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) 56.94%
- [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0010655](http://purl.obolibrary.org/obo/HP_0010655) (Epiphyseal stippling) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) 56.94%
- [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0009121](http://purl.obolibrary.org/obo/HP_0009121) (Abnormal axial skeleton morphology) and [HP:0010655](http://purl.obolibrary.org/obo/HP_0010655) (Epiphyseal stippling) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) 56.94%
- [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) and [HP:0010655](http://purl.obolibrary.org/obo/HP_0010655) (Epiphyseal stippling) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) 56.94%
- [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0001510](http://purl.obolibrary.org/obo/HP_0001510) (Growth delay) and [HP:0010655](http://purl.obolibrary.org/obo/HP_0010655) (Epiphyseal stippling) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) 56.94%
- [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) and [HP:0010655](http://purl.obolibrary.org/obo/HP_0010655) (Epiphyseal stippling) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) 56.94%
- [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0000929](http://purl.obolibrary.org/obo/HP_0000929) (Abnormality of the skull) and [HP:0010655](http://purl.obolibrary.org/obo/HP_0010655) (Epiphyseal stippling) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) 56.94%
- [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0000925](http://purl.obolibrary.org/obo/HP_0000925) (Abnormality of the vertebral column) and [HP:0010655](http://purl.obolibrary.org/obo/HP_0010655) (Epiphyseal stippling) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) 56.94%
- [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0000518](http://purl.obolibrary.org/obo/HP_0000518) (Cataract) and [HP:0010655](http://purl.obolibrary.org/obo/HP_0010655) (Epiphyseal stippling) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) 56.94%
- [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0000517](http://purl.obolibrary.org/obo/HP_0000517) (Abnormality of the lens) and [HP:0010655](http://purl.obolibrary.org/obo/HP_0010655) (Epiphyseal stippling) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) 56.94%


